OcuSciences Announces Publication Showing Potential to Detect Retinal Diseases with High Sensitivity
ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced a publication in Frontiers in Ophthalmology journal. By assessing the flavoprotein fluorescence in the retina with its flagship device, the OcuMet Beacon, these findings suggest that the novel FPF measure can detect retinal diseases with a high degree of sensitivity. This cross-sectional observational study, led by Ri